• Psychedelics - assisted therapy in


    Despite the huge therapeutic potential, psychedelic-assisted psychotherapy is not part of Montana's standard medical care yet. Self-medicating with psychedelics can produce undesired results, but despite that, more and more people feel disappointed with the efficacy of the current treatments and they turn to risky, but potentially more beneficial psychedelic-assisted therapy. The goal of this guide is harm reduction for people, who decided to self-medicate, we don’t encourage possession or consumption of illicit substances even for therapeutic endeavours.

    Book a video consultation Psychedelic integration

Psychedelics – assisted psychotherapy in Montana

Legal status of psychedelics in Montana

Montana, like the majority of states, keeps its drug laws straightforward. Schedules I-V are the five types of prohibited drugs. Drugs with the greatest potential for abuse and the fewest medical uses are classified as Schedule I. Hallucinogens are classified as Schedule I controlled dangerous substances in Montana.

Getting caught with a small amount of psychedelics could lead to being charged with a felony with a maximum of 5 years in jail and a maximum fine of $50,000.

The safest way to obtain psychedelics in Montana

It’s obvious that Montana’s state laws clearly prohibit magic mushrooms. While spores are alright to possess and sell, fully grown mushrooms containing psilocybin are illegal in the state of Montana. Probably the safest way to obtain psychedelics in Montana state is legally buying the spores and silently growing the mushrooms.



Montana had two ballot measures, one to legalize recreational cannabis and the other to make 21 the legal age to purchase, possess and consume cannabis. Voters approved both measures, despite the state’s Commerce Department’s opposition.

It gives hope, that with a growing body of evidence entheogenic plants will follow the same path. About two dozen companies and several nonprofits are leading active research of psychedelics.

Leaders of psychedelic research are hopeful that the next four years will continue to bring policy changes that end the federal prohibition of psilocybin, MDMA, and other psychedelics.